Goodwill

Ashtead Group plc Monitor

Ashtead Group plc Annual Report 2018
CR Monitor Issue: 
2019/0215
Company covered: 
Ashtead Group plc
Period End: 
30 April, 2018
Report issued on 26 February 2019 covered the following practice issues:
Pronouncements
Extended disclosure in respect of the expected future impacts of new accounting standards including IFRS 9 "Financial instruments".
Restatement
Change in segmental reporting structure with restatement of comparative information.
Change
Deferred tax changes recognised following changes to US tax legislation.
Restatement
Change in allocation of goodwill to cash generating units.
Change
Extended disclosure in respect of contingent liabilities.
New
Disclosure of level of fair value hierarchy for each non-derivative financial asset or liability and key inputs employed in the valuation of Level 3 financial instruments.

PZ Cussons Plc Monitor

PZ Cussons Plc Annual Report 2018
CR Monitor Issue: 
2019/0210
Company covered: 
PZ Cussons Plc
Period End: 
31 May, 2018
Report issued on 19 February 2019 covered the following practice issues:
Pronouncements
New disclosure in respect of the impact of new accounting standards including IFRS 9 "Financial instruments", IFRS 15 "Revenue from contracts with customers” and IFRS 16 “leases”.
Change
Extended disclosure of critical accounting judgements and estimates in relation to a change in exchange rate used for translation.
Restatement
De-recognition of a retirement benefit surplus following a change in respect of whether a unconditional right to refund exists.
Change
Discussion of key audit matters included in the audit report.
Change
Adiitional disclosure in relation to provision for potential tax liability.
Change
Sensitivity analysis presented in respect of goodwill impairment tests.

Renewi Plc Monitor

Renewi Plc Annual Report 2019
CR Monitor Issue: 
2019/0123
Company covered: 
Renewi Plc
Period End: 
31 March, 2018
Report issued on 31 January 2019 covered the following practice issues:
Pronouncements
Disclosure in respect of the impact of new accounting standards including IFRS 9 "Financial instruments", IFRS 15 "Revenue from contracts with customers and IFRS 16 “leases”.
Restatement
Finalisation of provisional fair values in respect of a prior year business acquisition.
Restatement
Restatement of non-controlling interest disclosures.
Change
Changes made to segmental reporting structure following integration of acquired entity.
Change
Exceptional tax credit recognised following change in Belgian tax rate.
Change
Change in allocation of goodwill to cash generating units for impairment test purposes.

DS Smith Plc Monitor

 DS Smith Plc Annual Report 2018
CR Monitor Issue: 
2019/0117
Company covered: 
DS Smith Plc
Period End: 
30 April, 2018
Report issued on 29 January 2019 covered the following practice issues:
Change
Detailed disclosure in respect of business acquisitions made during the year.
New
Recognition of biological assets linked to business acquisitions.
Change
Acquisition accounting identified as key audit matter.
Change
Alteration to reporting segments.
Pronouncements
Additional disclosure in respect of the expected impacts of new accounting standards including IFRS 9 "Financial instruments", IFRS 15 "Revenue from contracts with customers, IFRS 16 “leases”, and IFRIC 23 “Uncertainty over income tax treatment”.
Change
Change in allocation of goodwill to cash generating units for impairment test purposes.

Dechra Pharmaceuticals plc Monitor

Dechra Pharmaceuticals plc Annual Report 2018
CR Monitor Issue: 
2019/0115
Company covered: 
Dechra Pharmaceuticals plc
Period End: 
30 June, 2018
Report issued on 22 January 2019 covered the following practice issues:
Pronouncements
Disclosure in respect of the expected impact of new accounting standards including IFRS 9 "Financial instruments", IFRS 15 "Revenue from contracts with customers” and IFRS 16 “Leases”.
Change
Discussion of key audit matters included in the audit report including identification of a new key audit matter.
Change
Deferred tax changes recognised following changes to US tax legislation.
Change
Change in allocation of goodwill to cash generating units for impairment test purposes.
Change
Disclosure regarding remeasurement of contingent consideration.

UBM plc Monitor

UBM plc Annual Report 2017
CR Monitor Issue: 
2018/1012
Company covered: 
UBM plc
Period End: 
31 December, 2017
Report issued on 16 October 2018 covered the following practice issues:
Change
Discussion of a new key audit matter included in audit report.
Change
Separate sections outlining director and auditor responsibilities included in auditors' report.
Restatement
Finalisation of prior year business combination amounts results in prior year adjustments.
Change
Changes recognised in respect of operating segments following disposal.
Change
Deferred tax changes recognised following changes to US tax legislation.
Change
Re-appraisal of brands acquired in the previous year resulting in an increase in the useful economic life.

FirstGroup plc Monitor

First Group plc Annual Report 2018
CR Monitor Issue: 
2018/0905
Company covered: 
FirstGroup plc
Period End: 
31 March, 2018
Report issued on 10 September 2018 covered the following practice issues:
Change
Discussion of key audit matters included in audit report.
Pronouncements
Disclosure of reconciliation of movements in liabilities arising from financing activities.
Pronouncements
Extended disclosure in respect of the impacts of new accounting standards including IFRS 9 "Financial instruments", IFRS 15 "Revenues from contracts with customers" and IFRS 16 "Leases".
Change
Recognition of goodwill impairment based on difficult US trading conditions.
Change
Disclosure of a net asset breakdown in respect of business combination.
Change
Provision for onerous contract recognised in respect of rail franchise.

Tate & Lyle PLC Monitor

Tate & Lyle PLC Annual Report 2017-18
CR Monitor Issue: 
2018/0903
Company covered: 
Tate & Lyle PLC
Period End: 
31 March, 2018
Report issued on 3 September 2018 covered the following practice issues:
Change
Discussion of key audit matters included in audit report.
Pronouncements
Extended disclosure in respect of the impacts of new accounting standards: IFRS 9 "Financial instruments", IFRS 16 "Leases" and IFRIC 23 “Uncertainty over income tax treatments”.
Change
Change in reporting segments reflects economic characteristics and the management structure of the business.
Change
Change in allocation of goodwill to cash generating units for impairment test purposes.
Change
Recognition of exceptional tax credit linked to change in US tax laws.
Change
Disclosure of post balance sheet business acquisition agreement.

Micro Focus International plc Monitor

Micro Focus International plc Annual Report 2017
CR Monitor Issue: 
2018/0204
Company covered: 
Micro Focus International plc
Period End: 
30 April, 2017
Report issued on 13 February 2018 covered the following practice issues:
Change
Amortisation of capitalised research and development costs reclassified to cost of sales to achieve comparability.
Change
Goodwill recognised on business acquisition represents value of the assembled workforce and expected future economic benefits.
Pronouncements
Disclosures on amendments to IFRS 2.
Pronouncements
Qualitative disclosures on the future impacts of new revenue standard.
Change
Risk disclosures enhanced by inclusion of flow chart illustrating the risk management cycle.
Change
Disclosure of principal risk factors extended to identify competition as a new risk factor.

Halma plc Monitor

Halma plc Annual Report 2017
CR Monitor Issue: 
2018/0113
Company covered: 
Halma plc
Period End: 
1 April, 2017
Report issued on 30 January 2018 covered the following practice issues:
Restatement
Finalisation of provisional business combinations fair values results in restatement of prior year amounts in respect of one acquisition but adjustments are made in the current year in respect of another.
Change
Detailed description of the factors behind current year acquisition goodwill.
Pronouncements
Disclosure of expected impacts of new standards including IFRS 15, IFRS 9 and IFRS 16.
Change
Non-GAAP disclosures enhanced to include segment organic growth figures at constant currency rates.